Skip to main content
Doctors discuss and pointing on screen.

Clinically proven results

Tens of thousands of patients worldwide rely on Boston Scientific technology for relief from pain3. The effectiveness of Boston Scientific pain management therapies has also been proven in reducing chronic pain and improving quality of life.1

Spinal Cord Stimulation (SCS)

Aiming to get you back to everyday life with long-term relief

Improved Ability to do Everyday Activities (As measured by the Oswestry Disability Index).

The goal of SCS therapy is to get you back to doing the everyday things you enjoy, with relief you can rely on for the long-term.

In a multicentre clinical study conducted across 15 hospitals in the U.S., patients using Boston Scientific’s SCS therapies reported a great improvement in their ability to do everyday activities* sustained out to 2 years.1

Boston Scientific SCS therapy has helped tens of thousands of people around the world

Worldwide Success

Tens of thousands of people across the globe look to Boston Scientific SCS therapy for long-term, drug-free, ARTG included pain relief.3

90 percent success rate with Spinal Cord Stimulator trial

Successful Trials

At a single trial site in the United Kingdom conducted over a 7.5 year period, more than 90% of the Boston Scientific trial participants reported a successful experience and opted to get a permanent implant.2

95 percent of Boston Scientific patients would recommend Spinal Cord Stimulation

Patient Satisfaction

At a single trial site in the United Kingdom conducted over a 7.5 year period, 9 out of 10 patients said they were satisfied with their therapy and 95% would recommend it to others.2

See if Boston Scientific's pain management therapies are suitable for you

Take this quick quiz and find out

*As measured by the Oswestry Disability Index.

References:

  1.  Wallace M. et al., COMBO RCT: Combination therapy with simultaneous delivery of spinal cord stimulation modalities: COMBO randomised controlled trial. Pain Manag. (2023) 13(3), 171–184.
  2.  Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599. N=321
  3. Boston Scientific. (2008). Spinal Cord Stimulation Position Statement. Neuromodulation Therapy Access Coalition.

Results from clinical studies are not predictive of results in other studies. Results in other studies may vary. Results from different clinical investigations are not directly comparable. Information provided for educational purposes only.

Disclaimer and endnotes: 

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

Individual symptoms, situations, circumstances and results may vary. This quiz is meant for information purposes only, it is not intended to be used for medical diagnosis or treatment or as a substitute for professional medical advice. Please consult your doctor or qualified healthcare provider regarding your condition and appropriate medical treatment. This site is intended for Australian residents only. Please review the Boston Scientific Privacy Policy, for practices on the collection, storage, use and disclosure of your personal information.

Content of videos are for Information Purposes only and does not constitute medical advice. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

Talk to your healthcare professional about whether this product may be suitable for you as part of your overall plan to manage chronic pain. The WaveWriter Alpha System is not a first-line treatment for chronic intractable pain.

Surgery is required in order to use the WaveWriter Alpha System and any surgical procedure carries risk. Outcomes may vary for each patient. Patients should consult their healthcare professional about factors that could impact their response.

CAUTION: This product is not available for purchase by the general public. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.

Australia and New Zealand: Boston Scientific Pty Ltd | PO Box 332 Botany NSW 1455 Australia